Kordata Dynamics has emerged from stealth with the launch of an AI-powered precision clinical trials platform designed to improve the speed, quality, and accessibility of clinical research. The company also announced a pre-seed funding round backed by MAVRK Celestia Fund, Kern Venture Group, and Digital Neural Infrastructure Holdings (DNIH).
A spinout of BIOS Health, Kordata Dynamics is introducing a new model for precision clinical trials at scale, leveraging AI and neural biomarker technologies to enable faster and more precise trial execution. The launch comes during a period of increased industry momentum around modernizing clinical trials, including the FDA’s recent pilot initiative focused on real-time monitoring of clinical trial data.
Kordata’s platform incorporates BIOS Health’s proprietary AI precision dosing technology, NeuroTune, which analyzes neural data collected from invasive and non-invasive sources to provide real-time insights into patient responses to therapies and interventions. The company said the technology is designed to support high-quality clinical trial outcomes, particularly in complex therapeutic areas.
Initially, Kordata will focus on precision neuromodulation and neural therapies, targeting a market segment with an estimated $26 billion clinical trial backlog. The therapies being targeted span neurological and chronic diseases, including Alzheimer’s disease, Parkinson’s disease, epilepsy, cardiovascular disease, autoimmune disorders, and autonomic dysfunction.
The company said its AI-driven approach is intended to accelerate recruitment timelines, improve trial precision, and expand clinical trial participation to hospitals and healthcare systems that historically have not supported research programs. According to Kordata, only about 5% of U.S. hospitals have traditionally participated in clinical trials.
Kordata selected Bakersfield, California as the location for its inaugural site, citing the region’s large patient population, growing healthcare ecosystem, and proximity to industries with strong data-driven operational cultures. The company plans to use the location as a foundation for broader expansion into hospitals and clinical centers nationwide.
Kordata Dynamics President Dawn McCollough brings more than three decades of clinical trials experience, including participation in over 15,000 trials and involvement in bringing 27 drugs to market. McCollough previously held executive positions at Biogen and Novartis.
The company said it plans to connect regional clinicians, hospitals, and researchers with scientific and academic experts globally in order to accelerate innovation and improve access to precision medicine tools.
Kordata Dynamics is backed by Kern Venture Group, MAVRK Celestia Fund, BIOS Health, and Digital Neural Infrastructure Holdings. The company said its platform is designed to simplify the capture, processing, and interpretation of large-scale precision health data, helping transform complex clinical trial processes into more scalable and repeatable systems.
KEY QUOTES:
“That’s an exciting development for our field, and exactly what our model is designed for. The vision is for high quality trials that recruit in 3-6 months rather than over many years, provide clear data, and enfranchise vastly more patients and clinicians in the advancement of medicine.
Powered by BIOS’ technology, we can simplify dosing for complex medicines. We have collaborated with KVG, DNIH and MAVRK to launch Kordata Dynamics to take this further. The combination should unlock the treatments which otherwise might not come to light.”
Emil Hewage, CEO, Kordata Dynamics and BIOS Health
“At Kordata, we enable sponsors, sites, researchers and clinicians to access the benefits of AI-powered precision medicine tools previously out of reach, helping unlock the kind of high-quality, precise data and efficiencies that drives breakthroughs.
We honor the need for the best quality products and options for patients and along with that using technology and advancements that can extrapolate those possibilities. We’re excited to get off the ground, starting in Bakersfield.”
Dawn McCollough, President, Kordata Dynamics
